DIPASQUALE, Valeria
 Distribuzione geografica
Continente #
NA - Nord America 4.564
EU - Europa 4.254
AS - Asia 2.224
SA - Sud America 709
Continente sconosciuto - Info sul continente non disponibili 263
AF - Africa 67
OC - Oceania 3
Totale 12.084
Nazione #
US - Stati Uniti d'America 4.356
RU - Federazione Russa 2.230
SG - Singapore 891
BR - Brasile 584
CN - Cina 584
IE - Irlanda 510
IT - Italia 468
SE - Svezia 407
HK - Hong Kong 242
VN - Vietnam 149
DE - Germania 145
FR - Francia 110
PL - Polonia 104
GB - Regno Unito 89
IN - India 88
CA - Canada 74
FI - Finlandia 49
MX - Messico 47
TR - Turchia 42
BD - Bangladesh 39
ID - Indonesia 33
IQ - Iraq 32
AR - Argentina 26
CO - Colombia 26
AT - Austria 25
NL - Olanda 24
ZA - Sudafrica 22
EC - Ecuador 21
UZ - Uzbekistan 21
ES - Italia 19
VE - Venezuela 19
JP - Giappone 17
CR - Costa Rica 16
UA - Ucraina 16
CL - Cile 12
TT - Trinidad e Tobago 12
LT - Lituania 11
PK - Pakistan 11
JM - Giamaica 10
MA - Marocco 10
MY - Malesia 9
IL - Israele 8
PH - Filippine 8
HN - Honduras 7
KE - Kenya 7
NP - Nepal 7
TN - Tunisia 7
EE - Estonia 6
GP - Guadalupe 6
NI - Nicaragua 6
PY - Paraguay 6
SA - Arabia Saudita 6
AE - Emirati Arabi Uniti 5
AL - Albania 5
AZ - Azerbaigian 5
BG - Bulgaria 5
BO - Bolivia 5
GT - Guatemala 5
PE - Perù 5
SV - El Salvador 5
BE - Belgio 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
KZ - Kazakistan 4
MK - Macedonia 4
UY - Uruguay 4
AU - Australia 3
CI - Costa d'Avorio 3
CW - ???statistics.table.value.countryCode.CW??? 3
CY - Cipro 3
DK - Danimarca 3
GD - Grenada 3
LV - Lettonia 3
PR - Porto Rico 3
PT - Portogallo 3
TH - Thailandia 3
AO - Angola 2
AW - Aruba 2
BH - Bahrain 2
BM - Bermuda 2
BY - Bielorussia 2
CZ - Repubblica Ceca 2
EG - Egitto 2
ET - Etiopia 2
GR - Grecia 2
HU - Ungheria 2
JO - Giordania 2
KG - Kirghizistan 2
PS - Palestinian Territory 2
RS - Serbia 2
SC - Seychelles 2
AG - Antigua e Barbuda 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BJ - Benin 1
BS - Bahamas 1
CG - Congo 1
GA - Gabon 1
GE - Georgia 1
Totale 11.807
Città #
Ashburn 804
Moscow 612
Dublin 483
Singapore 461
Chandler 342
Dallas 307
San Jose 262
Hong Kong 240
Nyköping 201
Messina 198
Beijing 169
Council Bluffs 136
Warsaw 101
The Dalles 100
Los Angeles 96
Princeton 84
New York 68
Lauterbourg 61
Munich 60
Santa Clara 55
São Paulo 53
Medford 49
Dearborn 46
Des Moines 46
Ho Chi Minh City 40
Hanoi 37
Guangzhou 36
Orem 35
Menlo Park 34
Redondo Beach 34
Jacksonville 33
Buffalo 29
Tianjin 25
Phoenix 24
Brooklyn 23
North Bergen 23
Seattle 23
Chennai 21
Chicago 21
Frankfurt am Main 21
Turku 21
Vienna 21
Istanbul 20
Atlanta 19
London 19
Rome 18
Boardman 17
Denver 17
Nanjing 17
Reggio Calabria 17
Tashkent 17
Amsterdam 16
Belo Horizonte 16
Ann Arbor 15
Jakarta 15
Jinan 15
Mexico City 15
Milan 15
Helsinki 14
Palermo 14
Hyderabad 13
Johannesburg 13
Montreal 13
San Francisco 13
Tokyo 13
Wilmington 13
Baghdad 12
Brasília 12
Hangzhou 12
Nuremberg 12
Rio de Janeiro 12
San José 12
Houston 11
Lappeenranta 11
Madrid 11
Manchester 11
Bogotá 10
Bologna 10
Boston 10
Columbus 10
Curitiba 10
Dong Ket 10
Düsseldorf 10
Lawrenceville 10
Caltagirone 9
Caracas 9
Guayaquil 9
Naples 9
Stockholm 9
Taizhou 9
Toronto 9
Cambridge 8
Catania 8
Miami 8
Philadelphia 8
Bremen 7
Da Nang 7
Dhaka 7
Fortaleza 7
Mumbai 7
Totale 6.235
Nome #
Vaccinations and Immune Response in Celiac Disease 406
Headache and diplopia after rapid maxillary expansion: a clue to underdiagnosed pseudotumor cerebri syndrome? 380
Fibers in pediatric functional gastrointestinal disorders. Practical considerations from clinical cases 286
Mutations in the Neuronal Vesicular SNARE VAMP2 Affect Synaptic Membrane Fusion and Impair Human Neurodevelopment 244
A Narrative Review on Efficacy and Safety of Proton Pump Inhibitors in Children 237
Acute Malnutrition in Children: Pathophysiology, Clinical Effects and Treatment 229
Biallelic Variants in KIF17 Associated with Microphthalmia and Coloboma Spectrum 210
Adverse reactions related to proton pump inhibitors in pediatric population: an analysis of spontaneous reporting data 201
Managing Pediatric Foreign Body Ingestions: A 10-Year Experience 195
Inflammatory biomarkers and intellectual disability in patients with Down syndrome 188
Standard polymeric formula tube feeding in neurologically impaired children: A five-year retrospective study 181
Efficacy, safety, and pharmacokinetics of anti-TNF-α biosimilars in pediatric patients with inflammatory bowel diseases 180
Appropriate age at solid introduction: is EFSA extending the individualised window on a sounding scientific evidence? 179
Pseudotumor cerebri syndrome and renal diseases in the pediatric population 177
Breastfeeding and IL-10 levels in children affected by cow's milk protein allergy: A restrospective study 176
Tocilizumab for refractory uveitis associated with juvenile idiopathic arthritis: a report of two cases, Valeria Dipasquale, Marco Atteritano, Irene Castagna, Jlenia Fresta, Giovanni Conti 172
A loss-of-function homozygous mutation in DDX59 implicates a conserved DEAD-box RNA helicase in nervous system development and function 171
Caregiver Social Status and Health-Related Quality of Life in Neurologically Impaired Children on Home Enteral Nutrition 169
Antiemetic Drug Use in Children: What the Clinician Needs to Know 167
Prominent and regressive brain developmental disorders associated with nance-horan syndrome 167
Biosimilars in Pediatric Inflammatory Bowel Diseases: A Systematic Review and Real Life-Based Evidence 164
Neuroinflammation in Autism Spectrum Disorders: Role of High Mobility Group Box 1 Protein 162
Pericarditis during infliximab therapy in paediatric ulcerative colitis 162
An overview of the clinical management of cyclic vomiting syndrome in childhood 162
Update on the classification and pathophysiological mechanisms of pediatric cardiorenal syndromes 162
Biosimilar infliximab in paediatric inflammatory bowel disease: Efficacy, immunogenicity and safety 160
Adrenal disorders and the paediatric brain: pathophysiological considerations and clinical implications 159
Adalimumab Biosimilar in Pediatric Inflammatory Bowel Disease: A Retrospective Study from the Sicilian Network for Inflammatory Bowel Disease (SN-IBD) 159
Effectiveness and safety of biologics in pediatric inflammatory boweldisease: Real-life data from the Sicilian Network 155
Laparoscopic robotic-assisted restorative proctocolectomy and ileal J-pouch-anorectal anastomosis in children 155
Vaccination strategies in pediatric inflammatory bowel disease 154
Complementary feeding: new styles versus old myths 153
Cutaneous small-vessel vasculitis associated with paediatric ulcerative colitis: A case study and literature review 152
The management of colonic polyps in children: a 13-year retrospective study 152
Factors that influence infliximab biosimilar trough levels in the pediatric inflammatory bowel disease population 151
Thalidomide for de novo Crohn's disease after ileal pouch anal anastomosis for ulcerative colitis 151
Colectomy and health-related quality of life in children with ulcerative colitis 150
Spontaneous reporting of adverse reactions related to proton pump inhibitors 146
Surgery-related quality of life of pediatric patients with Crohn's disease 145
Clinical features and long-term outcomes in pediatric cyclic vomiting syndrome: A 9-year experience at three tertiary academic centers 145
Gastrointestinal symptoms in children: Primary care and specialist interface 144
Health-Related Quality of Life and Home Enteral Nutrition in Children with Neurological Impairment: Report from a Multicenter Survey 143
Pancreatic associated manifestations in pediatric inflammatory bowel diseases 143
Illegal immigration: The puzzling role of several risk factors for rhabdomyolysis 142
Diet and nutrition in pediatric inflammatory bowel diseases 142
Challenges in paediatric inflammatory bowel diseases in the COVID-19 time 140
A Systematic Review to Manage Avoidant/Restrictive Food Intake Disorders in Pediatric Gastroenterological Practice 134
Efficacy and safety of infliximab in very early onset inflammatory bowel disease: a national comparative retrospective study 132
Duodenal Duplication Cysts in Children: Clinical Features and Current Treatment Choices 132
Vedolizumab-associated pulmonary manifestations in children with ulcerative colitis 132
Clinical Course of Very Early-Onset Inflammatory Bowel Disease 130
Occurrence and Clinical Impact of Eosinophilic Esophagitis in a Large Cohort of Children With Inflammatory Bowel Disease 130
Pharmacological treatments and infectious diseases in pediatric inflammatory bowel disease 127
Real-Life Use of Biosimilars in Pediatric Inflammatory Bowel Disease: A Nation-Wide Web Survey on Behalf of the SIGENP IBD Working Group 127
Nutrition in pediatric gastroenterology 126
Impact of COVID-19 pandemic on the management of paediatric inflammatory bowel disease: An Italian multicentre study on behalf of the SIGENP IBD Group: Impact of the lockdown on IBD management in children 123
Risk Factors for Complications and Disease Recurrence after Ileocecal Resection for Crohn’s Disease in Children and Adults 122
Implications of SARS-COV-2 infection in the diagnosis and management of the pediatric gastrointestinal disease 121
Long-term Outcomes of Paediatric Patients Admitted With Acute Severe Colitis- A Multicentre Study From the Paediatric IBD Porto Group of ESPGHAN 118
Enhanced Recovery Care versus Traditional Care after Surgery in Pediatric Patients with Inflammatory Bowel Disease: A Retrospective Case-Control Study 114
Gastrointestinal and nutritional issues in children with neurological disability 108
Premenstrual asthma: A myth or a reality? 105
Clinical Features and Outcomes of Paediatric Patients with Isolated Colonic Crohn's Disease 104
Management of paediatric IBD after the peak of COVID-19 pandemic in Italy: A position paper on behalf of the SIGENP IBD working group 103
Management of Gastrointestinal and Nutritional Problems in Children with Neurological Impairment: A Survey of Practice 102
Early Tube Feeding Improves Nutritional Outcomes in Children with Neurological Disabilities: A Retrospective Cohort Study 98
Randomised controlled trial of melatonin for paediatric functional abdominal pain disorders 95
Bowel preparation and factors correlated with patients and parents 95
Octreotide: A Therapeutic Option for Pediatric Pseudotumor Cerebri Syndrome? 94
Top-ten tips for managing nutritional issues and gastrointestinal symptoms in children with neurological impairment 94
Real food in enteral nutrition for chronically ill children: overview and practical clinical cases 89
De Novo Crohn's Disease in Children With Ulcerative Colitis Undergoing Ileal Pouch-Anal Anastomosis: A Multicenter, Retrospective Study From the Pediatric IBD Porto Group of the ESPGHAN 85
Standard and Specialized Infant Formulas in Europe: Making, Marketing, and Health Outcomes 84
Pouchitis in pediatric ulcerative colitis: A multicenter study on behalf of Italian Society of Pediatric Gastroenterology, Hepatology and Nutrition 84
Disease course of ulcerative proctitis in children: A population-based study on behalf of the SIGENP IBD Group 76
null 76
Infections and malignancies risks related to TNF-α-blocking agents in pediatric inflammatory bowel diseases 74
New Therapeutic Challenges in Pediatric Gastroenterology: A Narrative Review 64
Real-life experience of infliximab biosimilar in pediatric-onset inflammatory bowel disease: data from the Sicilian Network for Inflammatory Bowel Disease 60
Different Vitamin D Supplementation Strategies in the First Years of Life: A Systematic Review 50
Vitamin D in Prevention of Autoimmune Diseases 47
Malnutrition management in children with chronic kidney disease 42
Genes vs environment in inflammatory bowel disease: an update 34
Gastrointestinal and nutritional care in pediatric neuromuscular disorders 33
Tube Feeding in Neurologically Disabled Children: Hot Topics and New Directions 31
Refeeding syndrome in pediatric age, an unknown disease: A narrative review 27
Kono-S Anastomosis in Pediatric Crohn’s Disease: Experience at a Tertiary Referral Center 26
Does the SCOPE (Sclerosing Cholangitis Outcomes in PEdiatrics) index effectively predict later liver transplantation in children with sclerosing cholangitis? 23
Infliximab biosimilar GP1111: a review of 5 years’ post-approval experience 20
Long‐term safety and durability of multiple anti‐TNFα switches in pediatric inflammatorybowel disease: A SIGENP multicenter study 12
Eosinophilic esophagitis in children and adolescents: a clinical practice guideline 9
COMPLY-CATeD: Celiac Adherence in Teens Diagnosed: an Italian multicentric study 4
Totale 12.084
Categoria #
all - tutte 42.958
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.958


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022459 0 0 0 0 53 1 25 17 34 109 39 181
2022/20231.351 100 141 54 79 74 140 22 100 577 8 34 22
2023/2024333 23 60 23 30 21 53 14 46 1 23 4 35
2024/20251.888 25 47 38 169 92 74 61 301 408 165 181 327
2025/20265.579 318 333 369 353 497 1.044 640 739 734 292 120 140
2026/20271.638 393 373 386 483 3 0 0 0 0 0 0 0
Totale 12.084